Actively Recruiting
Global Initiative on Takayasu Arteritis (GITA)
Led by Marmara University · Updated on 2026-04-30
1000
Participants Needed
2
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Takayasu's Arteritis Global Registry aims to bring a large group of patients from different parts of the world to analyse and compare the patients' demographic, clinical, laboratory, radiological and prognostic features with outcomes, approaches to diagnosis, assessment, management and therapeutic interventions in different centers. The present project provides for both a retrospective and a prospective longitudinal study. The study is designed as retrospective for patients already diagnosed with TAK and treated with available treatments. Also, the study is designed as prospective for patients diagnosed with TAK after the initiation of the Registry or the adhesion to the project. This is thought as a multicentre, international study addressed to all Centers that will want to contribute to the present project. The study is non-interventional: demographic, clinical and therapeutic data required over time are collected with the routine diagnostic, clinical and therapeutic procedures usually carried out for the optimal management of patients and according with good clinical practice.
CONDITIONS
Official Title
Global Initiative on Takayasu Arteritis (GITA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Each patient must fulfill the ACR 1990 or ACR/EULAR 2021 criteria for Takayasu arteritis
- Patients or their legal representatives must provide informed and free agreement to participate
- Participants or their representatives must willingly comply with study protocol requirements for the study duration
- Participants must sign written and dated informed consent after being fully informed about the study
- Participants are informed they can withdraw consent at any time without affecting future medical care
You will not qualify if you...
- Patients who do not fulfill the ACR 1990 or ACR/EULAR 2021 criteria for Takayasu arteritis
- Patients who do not provide or sign informed consent or assent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Marmara University School of Medicine
Istanbul, Istanbul, Turkey (Türkiye), 34899
Actively Recruiting
2
Marmara University School of Medicine
Istanbul, Istanbul, Turkey (Türkiye), 34899
Actively Recruiting
Research Team
F
Fatma Alibaz-Oner, Professor, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here